DRTSW

This security represents warrants of Alpha Tau Medical Ltd., a medical device company developing cancer radiation therapy technology. Each warrant typically entitles the holder to purchase one share of ordinary shares at a predetermined exercise price. These warrants were likely issued in connection with Alpha Tau's public offering or business combination. The warrants provide leveraged exposure to the company's progress in clinical development, regulatory approvals, and commercialization of its Alpha DaRT technology. Warrant holders participate in potential upside while risking the warrant premium if the stock price remains below the exercise price.